[New clinical perspectives in the management of oral direct anticoagulant agents]

MeSH terms

• Administration, Oral
• Anticoagulants / administration & dosage
• Anticoagulants / adverse effects
• Anticoagulants / therapeutic use*
• Atrial Fibrillation / complications
• Benzimidazoles / administration & dosage
• Benzimidazoles / adverse effects
• Benzimidazoles / therapeutic use
• Dabigatran
• Elective Surgical Procedures
• Emergencies
• Factor Xa Inhibitors
• Hemorrhage / chemically induced
• Humans
• Kidney Diseases / metabolism
• Morpholines / administration & dosage
• Morpholines / adverse effects
• Morpholines / therapeutic use
• Orthopedic Procedures
• Postoperative Complications / drug therapy
• Postoperative Complications / etiology
• Premedication
• Pyrazoles / administration & dosage
• Pyrazoles / adverse effects
• Pyrazoles / therapeutic use
• Pyridines / administration & dosage
• Pyridines / adverse effects
• Pyridines / therapeutic use
• Pyridones / administration & dosage
• Pyridones / adverse effects
• Pyridones / therapeutic use
• Randomized Controlled Trials as Topic
• Risk
• Rivaroxaban
• Thiophenes / administration & dosage
• Thiophenes / adverse effects
• Thiophenes / therapeutic use
• Thrombophilia / drug therapy*
• Thrombophilia / etiology
• Vitamin K / antagonists & inhibitors